As capital markets advance into a new phase of high-quality development, the role of the Board Secretary remains pivotal, serving as a crucial link between companies and their vast investor base, shaping capital brands, and building market trust.
In this edition of the Board Secretary's View, Secretary Hu Yan from B-Soft shares insights into the company's journey.
Sina Finance: Welcome, Ms. Hu. Could you provide an overview of the company?
Hu Yan: Thank you for the invitation. B-Soft Co.,Ltd. (SHE: 300451), founded in 1997 and listed on the Shenzhen Stock Exchange's ChiNext board in 2015, is dedicated to "creating smart healthcare and serving the health industry." The company has long been a leader in healthcare information technology, offering products for smart medical care, public health, medical insurance, health, and elderly care. Headquartered in Hangzhou, its operations span over 30 provinces, autonomous regions, and municipalities across China.
In recent years, aligned with national digital and health initiatives, the company has focused on its core business, driving the cloudification, platformization, and intelligent upgrade of its products. It has iterated core offerings like the new-generation HI-HIS and comprehensive smart hospital solutions. Adhering to a dual-drive strategy of "medical informatization + AI," it leverages big data and artificial intelligence to empower the entire medical landscape. With its "Huikang Cloud Pivot Intelligent Body" as the core technological foundation, the company is actively transitioning from a technology cloud ecosystem enterprise to an intelligent cloud ecosystem enterprise. AI technology is integrated throughout the entire process of medical software development, product upgrades, scenario implementation, and service optimization, focusing on core areas such as clinical diagnosis and treatment, hospital management, public health, and primary care. The company continuously builds intelligent solutions covering clinical, management, and data dimensions to support the upgrade of the value supply chain within the healthcare IT industry ecosystem.
Sina Finance: How do you understand the role of a Board Secretary?
Hu Yan: As the company's Board Secretary, one serves as both the organizer of standardized operations for a listed company and the bridge connecting the capital market with corporate operations. On one hand, it involves strictly fulfilling information disclosure duties to ensure information is truthful, accurate, and complete. On the other hand, it requires effective investor relations management to communicate company value and relay market concerns to management, thereby aiding in governance and operational capability enhancement.
Sina Finance: You mentioned the "medical informatization + AI" dual-drive strategy. How does the company position AI strategically within its operations, R&D, production, and management?
Hu Yan: The company places high importance on the application value of AI technology in the healthcare IT field, viewing AI as a crucial technical direction for driving product upgrades, service optimization, and operational efficiency improvements. Centered on core business scenarios like smart medical care, smart public health, medical insurance, public health, and health management, the company continuously promotes the integration of AI with medical industry knowledge bases, data governance, clinical workflows, and hospital operational management. It explores AI-assisted R&D, intelligent product upgrades, and enhancements to the "Huikang Cloud" architecture. In terms of operational management, the company will also prudently advance the application of AI tools in conjunction with R&D, delivery, operation and maintenance, customer service, and internal operational processes, continuously improving organizational efficiency and the intelligence level of its solutions.
Sina Finance: How do you believe AI will reshape the competitive landscape of your industry? What measures is the company taking to maintain its first-mover advantage?
Hu Yan: The deep application of AI technology will propel the healthcare IT industry from system construction towards platformization, intelligence, and continuous operational service upgrades. Future competition will increasingly focus on a company's understanding of medical business scenarios, product platform capabilities, data governance capabilities, algorithm application capabilities, compliance and security capabilities, and continuous delivery capabilities. Having long been entrenched in the healthcare IT sector, the company has accumulated substantial customer resources, business scenarios, and industry experience. It continues to advance its "Huikang Cloud" strategy and AI-related product capability development, exploring products and applications around the "Huikang Cloud Pivot Intelligent Body" and BsoftGPT. Simultaneously, the company actively strengthens collaboration with medical institutions, universities, research institutes, and industry ecosystem partners to promote the validation and productization of AI capabilities in real-world medical scenarios, striving to consolidate its comprehensive competitiveness in the healthcare IT field.
Sina Finance: Empowered by AI, how will the company reshape its business model and enhance operational efficiency and core competitiveness?
Hu Yan: Regarding business models, the company will actively explore extending from traditional project-based delivery to cloud platform services, intelligent applications, data governance services, and scenario-based solutions, aligning with the digital and intelligent upgrade needs of medical institutions. Focusing on scenarios like clinical assistance, patient management, medical record quality control, medical insurance cost control, hospital operational management, and public health early warning, the company will continue integrating AI with its core products to help clients improve medical service efficiency and refined management levels. Internally, the company will explore the application of AI tools in software development, testing, project management, knowledge base construction, operation and maintenance response, and customer service to enhance delivery quality and operational efficiency.
In the future, the company's core competitiveness will be further reflected in the comprehensive synergy of industry scenario insight, platform-based product capabilities, data security governance capabilities, compliant delivery capabilities, and continuous service capabilities.
Sina Finance: What are the company's top-level considerations regarding AI application compliance, data security, and intelligent governance?
Hu Yan: Medical and health data is highly sensitive. The company always prioritizes data security, personal information protection, and compliance governance. In the AI application process, the company adheres to relevant laws and regulations such as the Cybersecurity Law, Data Security Law, and Personal Information Protection Law, upholding the principles of compliance first, security and controllability, scenario adaptation, and prudent implementation. Technologically and managerially, the company will continuously improve its governance system around data classification and grading, minimal necessary use, authorization management, access control, encryption protection, de-identification, log auditing, supplier management, and emergency response. For applications involving generative AI, intelligent agents, and third-party large models, the company will prudently handle matters related to data usage, model invocation, content security, intellectual property, personal information protection, and output review, clarifying the boundary between AI assistance and human decision-making to ensure these technologies empower medical business scenarios under legal, compliant, secure, and reliable premises.
Sina Finance: From the perspective of the current industry cycle, how does the company understand the core essence of high-quality development for listed companies?
Hu Yan: We believe that high-quality corporate development is reflected not only in scale growth but also in the continuous improvement of development quality, innovation capability, and sustainable operational capacity. For the healthcare IT industry, high-quality development means continuously creating customer value, enhancing technological innovation and product competitiveness, steadily improving operational quality and efficiency, and establishing a long-term, stable development mechanism. The industry is currently accelerating its evolution from the traditional informatization construction phase to the digital and intelligent development stage. Only by adhering to long-termism and being driven by innovation and value creation can the company achieve sustainable growth amidst industry transformation.
Sina Finance: What are the company's top-level strategic layouts for deepening its main business, iterating its industry offerings, and improving quality and efficiency?
Hu Yan: Currently, the wave of digitalization in the healthcare industry is burgeoning. As a pioneer, the company is fully committed to its strategic transformation. While this process is challenging, it is profoundly significant. The core of this transformation lies in reshaping the landscape of healthcare services through technological empowerment to create inclusive social value. Presently, the company's product system is maturing, and new-generation delivery models are being steadily implemented. All members are actively learning and evolving with an open attitude, fully embracing the opportunities and challenges of this new development phase.
To actively embrace the wave of technological change, the company has proactively laid out plans in the AI and data element domains, vigorously introducing high-level professional talent. Concurrently, it is comprehensively promoting internal employee capability upgrades, encouraging staff participation in new technology and application training. Talent is the core driving force for enterprise development, and the continuous growth of a professional, innovative team is injecting a steady stream of momentum for the company's high-quality development.
In terms of business layout, the company deeply focuses on the independent R&D and continuous innovation of core medical systems. It collaborates with major tertiary hospitals and research institutions to vigorously develop the construction and iteration of hospital core information systems, primary care systems, and public health management platforms. These collaborations form a solid foundation for the continuous development of the company's product solutions and service system.
Simultaneously, the company consistently upholds the concept of open collaboration and professional division of labor, actively building a new ecosystem for medical digitalization cooperation. For non-core areas, the company actively engages in technical adaptation and joint verification with various high-quality manufacturers, enhancing the maturity and reliability of overall solutions through complementary strengths. Through this layered collaboration model, the company not only consolidates its self-controllable core capabilities but also integrates broader industrial ecosystem forces to jointly promote the high-quality development of medical digitalization.
From solidifying talent strategy reserves to cope with rapid technological iteration, to continuously expanding collaborations with tertiary hospitals to enhance product performance through demand, and to building a collaborative and win-win industrial ecosystem, the company always adheres to the corporate spirit of "being down-to-earth, daring to act, and acting wisely." It innovates pragmatically and advances through breakthroughs, continuously reinforcing the company's long-term value. All of this will imbue "New B-Soft, Smart Health" with deeper meaning, provide a superior path for the high-quality development of the medical informatization industry, and forge a solid cornerstone for digital health.
Sina Finance: How do you view the deep interrelationship between ESG and corporate valuation, institutional investment, and long-term development?
Hu Yan: ESG has strong synergies with long-term corporate development. It has become a significant consideration in the competition within the healthcare IT industry. As an industry closely related to people's livelihoods, healthcare IT bears the responsibility of social accountability, making ESG's importance to the company self-evident. Excellent ESG performance can reduce operational risks, shape a positive corporate image, and attract high-quality clients and employees. Strong ESG performance helps elevate corporate governance, enhance risk resilience, optimize resource allocation, and also aids in gaining the attention and recognition of long-term capital and institutional investors.
While practicing ESG principles, the company is also laying the groundwork for its future long-term development. On its continuous exploration of the ESG path, the company will maintain high levels of R&D investment, explore innovation service development directions for healthcare informatization under the goal of smart hospitals, strengthen internal governance and compliant operations, accelerate the transition from an IT information product and service company to a technology cloud ecosystem enterprise, and realize the company's long-term development. Guided by ESG principles, the company contributes to building a sound healthcare security system, promoting the universality and digital intelligence of medical services, advancing the implementation of the "Healthy China 2030" long-term development strategy, enhancing people's health and well-being, thereby boosting the company's brand influence, setting industry benchmarks, and leading the healthcare IT industry towards greener and smarter development.
Sina Finance: Thank you for your detailed answers, which we believe give investors a deeper understanding of the company's development. Finally, could you share your views and suggestions on AI development in the industry?
Hu Yan: Medical AI is a vital direction for the long-term development of the healthcare IT industry, but its implementation requires a balanced focus on scenario traction, value verification, and compliance and security. Industry players should concentrate on real pain points in clinical, public health, medical insurance, and hospital operational management processes, emphasizing the practical value of AI in improving medical quality, optimizing service processes, enhancing administrative efficiency, assisting clinical decision-making, and strengthening risk control. Simultaneously, the development of medical AI requires collaboration among medical institutions, IT enterprises, academic research institutions, and regulatory bodies to jointly advance the standardization of medical data, system interconnectivity, algorithm evaluation, ethical review, and the construction of security and compliance systems. B-Soft will continue to base itself on its core healthcare IT business, prudently advancing the application of AI technology in scenarios such as smart medical care, smart public health, medical insurance, public health, and health management, providing more reliable products and services for the digital and intelligent upgrade of medical institutions.
Comments